Literature DB >> 28650452

Development of quality of life in patients undergoing allogeneic stem cell transplantation with regard to anxiety, depression and resilience.

A Schumacher1, C Sauerland2, G Silling3, W E Berdel1, M Stelljes1, R Koch2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28650452     DOI： 10.1038/bmt.2017.123

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation.

Authors:  Jesús M Prieto; Jorge Atala; Jordi Blanch; Enric Carreras; Montserrat Rovira; Esteve Cirera; Anna Espinal; Cristóbal Gasto
Journal:  J Clin Oncol       Date:  2005-08-08       Impact factor: 44.544

2.  [Anxiety and depression in the general population: normal values in the Hospital Anxiety and Depression Scale].

Authors:  A Hinz; R Schwarz
Journal:  Psychother Psychosom Med Psychol       Date:  2001-05

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  Development and psychometric evaluation of the Resilience Scale.

Authors:  G M Wagnild; H M Young
Journal:  J Nurs Meas       Date:  1993

5.  Resource loss, resource gain, and psychological resilience and dysfunction following cancer diagnosis: a growth mixture modeling approach.

Authors:  Wai Kai Hou; Chi Ching Law; Jing Yin; Yiu Tung Fu
Journal:  Health Psychol       Date:  2010-09       Impact factor: 4.267

6.  Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation.

Authors:  Norbert Grulke; Wolfgang Larbig; Horst Kächele; Harald Bailer
Journal:  Psychooncology       Date:  2008-05       Impact factor: 3.894

7.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

9.  Resilience in patients after allogeneic stem cell transplantation.

Authors:  Andrea Schumacher; Cristina Sauerland; Gerda Silling; Wolfgang E Berdel; Matthias Stelljes
Journal:  Support Care Cancer       Date:  2013-10-08       Impact factor: 3.603
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.